Authors:
Thurnher, D
Kornfehl, J
Burian, M
Gedlicka, C
Selzer, E
Quint, C
Neuchrist, C
Kornek, GV
Citation: D. Thurnher et al., Ifosfamide and mitoxantrone in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck, ANTI-CANC D, 12(3), 2001, pp. 205-208
Authors:
Quint, C
Temmel, AFP
Schickinger, B
Pabinger, S
Ramberger, P
Hummel, T
Citation: C. Quint et al., Patterns of non-conductive olfactory disorders in eastern Austria: A studyof 120 patients from the Department of Otorhinolaryngology at the University of Vienna, WIEN KLIN W, 113(1-2), 2001, pp. 52-57
Authors:
Thurnher, D
Kletzmayr, J
Formanek, M
Quint, C
Czerny, C
Burian, M
Kornek, G
Citation: D. Thurnher et al., Chemotherapy-related hemolytic-uremic syndrome following treatment of a carcinoma of the nasopharynx, ONCOL-BASEL, 61(2), 2001, pp. 143-146
Authors:
Temmel, AFP
Quint, C
Toth, J
Herneth, A
Hummel, T
Citation: Afp. Temmel et al., Topical ephedrine administration and nasal chemosensory function in healthy human subjects, ARCH OTOLAR, 125(9), 1999, pp. 1012-1014
Authors:
Quint, C
Neuchrist, C
Breitschopf, H
Pammer, J
Burian, M
Citation: C. Quint et al., Expression of basic fibroblast growth factor in squamous cell carcinomas of the larynx - Examination by in situ hybridization, ONKOLOGIE, 22(1), 1999, pp. 41-46
Authors:
Neuchrist, C
Quint, C
Pammer, A
Burian, M
Citation: C. Neuchrist et al., Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: an immunohistochemical study, ACT OTO-LAR, 119(6), 1999, pp. 732-738